Massive Bio
Empowering cancer patients globally through AI-based clinical trial matching
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B2C
- Website
- massivebio.com
- Total Funding
- $32.1M
- Last Round
- $16.5M Series BDec 2022
About
Massive Bio is a New York-based AI-driven oncology platform that connects cancer patients and their physicians to biopharmaceutical clinical trials globally. Its SYNERGY AI engine matches patients to suitable trials based on clinical and genomic data, while its Virtual Tumor Board — comprising specialists from 25 U.S. cancer research facilities — provides personalized treatment recommendations when trial matches are unavailable. The service is always free for patients and addresses the gap whereby most U.S. cancer patients receive care in community practices rather than specialized cancer centers. Massive Bio is the official matchmaking partner for all NCI-funded clinical trials.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.